DE3601923A1
(de)
*
|
1986-01-23 |
1987-07-30 |
Behringwerke Ag |
Nasal applizierbares arzneimittel, verfahren zu seiner herstellung und seine verwendung
|
MY102411A
(en)
*
|
1986-12-23 |
1992-06-17 |
Ciba Geigy Ag |
Nasal solutions
|
US5059587A
(en)
*
|
1987-08-03 |
1991-10-22 |
Toyo Jozo Company, Ltd. |
Physiologically active peptide composition for nasal administration
|
KR890006252A
(ko)
*
|
1987-10-15 |
1989-06-12 |
헤르비그 폰 모르체 |
분말형 폴리펩타이드의 비강내 투여용 조성물 및 투여방법
|
NZ228285A
(en)
*
|
1988-03-11 |
1991-08-27 |
Teikoku Seiyaku Kk |
Pharmaceutical composition comprising a polypeptide and adapted for intravaginal administration
|
US5260270A
(en)
*
|
1988-03-30 |
1993-11-09 |
The Johns Hopkins University |
Odorant-binding protein from rat
|
EP0360340A1
(de)
*
|
1988-09-19 |
1990-03-28 |
Akzo N.V. |
Peptidenthaltende Zubereitung zur intranasalen Verabreichung
|
US5514365A
(en)
*
|
1988-10-11 |
1996-05-07 |
Schiapparelli Salute S.P.A. |
Pharmaceutical compositions comprising calcitonin for intranasal administration
|
IL91856A0
(en)
*
|
1988-10-11 |
1990-06-10 |
Schiapparelli Salute Spa |
Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same
|
JPH02104531A
(ja)
*
|
1988-10-14 |
1990-04-17 |
Toyo Jozo Co Ltd |
経鼻投与用生理活性ペプチド組成物
|
US5567682A
(en)
*
|
1988-12-16 |
1996-10-22 |
Advanced Peptides And Biotechnology Sciences |
Method of treating Alzheimer's disease
|
JP2704546B2
(ja)
*
|
1989-04-04 |
1998-01-26 |
光利 太良 |
Atll治療用吸入剤
|
JP2514249B2
(ja)
*
|
1989-05-23 |
1996-07-10 |
帝人株式会社 |
安定化されたカルシトニン類医薬組成物
|
US5422340A
(en)
*
|
1989-09-01 |
1995-06-06 |
Ammann; Arthur J. |
TGF-βformulation for inducing bone growth
|
JP2911496B2
(ja)
*
|
1989-09-11 |
1999-06-23 |
帝國製薬株式会社 |
生理活性ポリペプチド含有高吸収性経膣剤
|
DE69001991T2
(de)
*
|
1989-11-16 |
1993-09-23 |
Phidea Spa |
Fluessige arzneimittel zur nasalen anwendung, die ein polypeptid als wirksubstanz enthalten.
|
GB9000459D0
(en)
*
|
1990-01-09 |
1990-03-07 |
James Michael H |
Medicaments for treatment of airborne allergies
|
US5681814A
(en)
*
|
1990-06-07 |
1997-10-28 |
Genentech, Inc. |
Formulated IGF-I Composition
|
US5780012A
(en)
*
|
1990-06-21 |
1998-07-14 |
Huland; Edith |
Method for reducing lung afflictions by inhalation of cytokine solutions
|
ES2065434T3
(es)
*
|
1990-06-21 |
1995-02-16 |
Edith Dr Huland |
Utilizacion de aerosoles que contienen citocinas y aerosoles que contienen citocinas propiamente dichos.
|
IL99699A
(en)
*
|
1990-10-10 |
2002-04-21 |
Autoimmune Inc |
Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
|
IT1242019B
(it)
*
|
1990-11-20 |
1994-02-02 |
Ripari Gero Ist Farm Biolog |
Composizioni farmaceutiche acquose a base di calcitonina, da somministrarsi per via nasale.
|
JP3179538B2
(ja)
*
|
1990-12-11 |
2001-06-25 |
ノバルティス アクチエンゲゼルシャフト |
安定なヒトカルシトニンの水性溶液
|
US5093105A
(en)
*
|
1991-04-09 |
1992-03-03 |
Merck Frosst Canada, Inc. |
Radiopharmaceutical bacteriostats
|
US5227152A
(en)
*
|
1991-04-09 |
1993-07-13 |
Merck Frosst Canada, Inc. |
Radiopharmaceutical bacteriostats
|
US5306482A
(en)
*
|
1991-04-09 |
1994-04-26 |
Merck Frosst Canada, Inc. |
Radiopharmaceutical bacteriostats
|
WO1992020367A1
(en)
*
|
1991-05-24 |
1992-11-26 |
Amylin Pharmaceuticals, Inc. |
Treatment of anorexia and related states
|
DE4222647A1
(de)
*
|
1991-07-15 |
1993-01-21 |
Sandoz Ag |
Peptid-zubereitungen
|
AU2348492A
(en)
*
|
1991-07-19 |
1993-02-23 |
East Carolina University |
Method of treating asthma
|
US5571788A
(en)
*
|
1991-12-09 |
1996-11-05 |
Ciba-Geigy Corporation |
Stable calcitonin pharmaceutical compositions
|
US5192743A
(en)
*
|
1992-01-16 |
1993-03-09 |
Genentech, Inc. |
Reconstitutable lyophilized protein formulation
|
AU659328B2
(en)
*
|
1992-06-12 |
1995-05-11 |
Teijin Limited |
Ultrafine powder for inhalation and production thereof
|
KR100208979B1
(ko)
*
|
1992-06-12 |
1999-07-15 |
야스이 쇼사꾸 |
기도내 투여용 제제
|
DK17093D0
(da)
*
|
1993-02-15 |
1993-02-15 |
Lyfjathroun H F |
Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder
|
CZ282456B6
(cs)
*
|
1993-06-29 |
1997-07-16 |
Ferring B. V. |
Kompozice pro nasální podání desmopressinu
|
US5482931A
(en)
*
|
1993-06-29 |
1996-01-09 |
Ferring Ab |
Stabilized pharmaceutical peptide compositions
|
EP0748213B1
(de)
|
1994-03-07 |
2004-04-14 |
Nektar Therapeutics |
Verfahren und mittel zur verabreichung von insulin über die lunge
|
JP3098401B2
(ja)
*
|
1995-07-12 |
2000-10-16 |
株式会社エルティーティー研究所 |
経鼻投与用製剤
|
WO1997039761A1
(en)
|
1996-04-19 |
1997-10-30 |
Alpha Therapeutic Corporation |
A process for viral inactivation of lyophilized blood proteins
|
US8765177B2
(en)
*
|
1997-09-12 |
2014-07-01 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US7153845B2
(en)
*
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US6190699B1
(en)
*
|
1998-05-08 |
2001-02-20 |
Nzl Corporation |
Method of incorporating proteins or peptides into a matrix and administration thereof through mucosa
|
DE19826628C1
(de)
*
|
1998-06-17 |
2000-07-20 |
Werner Kern |
Intranasale Verwendung von Insulin bei Hirnleistungsstörungen
|
US20060171899A1
(en)
*
|
1998-12-10 |
2006-08-03 |
Akwete Adjei |
Water-stabilized aerosol formulation system and method of making
|
US6540982B1
(en)
*
|
2000-01-25 |
2003-04-01 |
Aeropharm Technology Incorporated |
Medical aerosol formulation
|
US20030138460A1
(en)
*
|
2000-02-08 |
2003-07-24 |
Allergan, Inc |
Methods of treating animals with botulinum toxin pharmaceutical compositions
|
DK1253932T3
(da)
*
|
2000-02-08 |
2005-06-27 |
Allergan Inc |
Lægemidler med botulinustoxin
|
US8632785B2
(en)
*
|
2000-02-08 |
2014-01-21 |
Allergan, Inc. |
Clostridial toxin pharmaceutical composition containing a gelatin fragment
|
US7780967B2
(en)
*
|
2000-02-08 |
2010-08-24 |
Allergan, Inc. |
Reduced toxicity Clostridial toxin pharmaceutical compositions
|
US20060269575A1
(en)
*
|
2000-02-08 |
2006-11-30 |
Allergan, Inc. |
Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
|
US20030118598A1
(en)
*
|
2000-02-08 |
2003-06-26 |
Allergan, Inc. |
Clostridial toxin pharmaceutical compositions
|
JP4711520B2
(ja)
*
|
2000-03-21 |
2011-06-29 |
日本ケミカルリサーチ株式会社 |
生理活性ペプチド含有粉末
|
US20020146409A1
(en)
*
|
2001-01-30 |
2002-10-10 |
Herring Steven W. |
Methods for stabilizing lyophilized blood proteins
|
DK1372611T3
(da)
*
|
2001-03-26 |
2006-09-18 |
Novartis Ag |
Farmaceutisk sammensætning omfattende staurosporin med ringe vandoplöselighed, et overfladeaktivt stof og en vandoplöselig polymer
|
WO2003072016A2
(en)
*
|
2001-11-19 |
2003-09-04 |
Becton, Dickinson And Company |
Pharmaceutical compositions in particulate form
|
US20040005999A1
(en)
*
|
2002-03-07 |
2004-01-08 |
Andreasen Kasper Huus |
Polyamino acid-based particle insulin preparation
|
US7812120B2
(en)
|
2003-03-21 |
2010-10-12 |
Par Pharmaceutical, Inc. |
Nasal calcitonin formulations containing chlorobutanol
|
US20050058673A1
(en)
|
2003-09-09 |
2005-03-17 |
3M Innovative Properties Company |
Antimicrobial compositions and methods
|
AU2004317954A1
(en)
*
|
2003-09-17 |
2005-10-13 |
Chiasma, Inc. |
Compositions capable of facilitating penetration across a biological barrier
|
US9028852B2
(en)
*
|
2004-09-07 |
2015-05-12 |
3M Innovative Properties Company |
Cationic antiseptic compositions and methods of use
|
US20060051384A1
(en)
*
|
2004-09-07 |
2006-03-09 |
3M Innovative Properties Company |
Antiseptic compositions and methods of use
|
US8198326B2
(en)
*
|
2004-09-07 |
2012-06-12 |
3M Innovative Properties Company |
Phenolic antiseptic compositions and methods of use
|
EP1824450B1
(de)
*
|
2004-10-11 |
2012-11-14 |
Nasaleze Patents Limited |
Zusammensetzungen für die intranasale verabreichung
|
GB0422582D0
(en)
*
|
2004-10-11 |
2004-11-10 |
Nasaleze Patents Ltd |
Pharmaceutical compositions
|
US7396936B1
(en)
|
2004-11-09 |
2008-07-08 |
Kemia, Inc. |
Modulators of calcitonin and amylin receptor activity
|
WO2006099325A2
(en)
*
|
2005-03-10 |
2006-09-21 |
3M Innovative Properties Company |
Methods of treating ear infections
|
WO2006099358A2
(en)
*
|
2005-03-10 |
2006-09-21 |
3M Innovative Properties Company |
Antimicrobial compositions comprising esters of hydroxycarboxylic acids
|
EP3025704B1
(de)
*
|
2005-03-10 |
2019-01-16 |
3M Innovative Properties Company |
Verfahren zur verringerung von mikrobieller kontamination
|
US7580130B2
(en)
*
|
2005-03-23 |
2009-08-25 |
Datacolor Holding Ag |
Method for designing a colorimeter having integral illuminant-weighted CIE color-matching filters
|
JP2007084508A
(ja)
*
|
2005-09-26 |
2007-04-05 |
Shiseido Co Ltd |
新規血管内皮増殖因子発現阻害剤
|
BRPI0716325A2
(pt)
|
2006-10-27 |
2014-03-04 |
3M Innovative Properties Co |
Composição antimicrobianas
|
US9789071B2
(en)
|
2012-06-27 |
2017-10-17 |
G2B Pharma, Inc. |
Intranasal formulation of epinephrine for the treatment of anaphylaxis
|
AU2014315459A1
(en)
*
|
2013-09-03 |
2016-04-07 |
G2B Pharma Inc. |
Intranasal formulation for the treatment of cardiopulmonary resuscitation (CPR), cardiac life support (CLS), anaphylaxis and/or anaphylactoid reactions
|